Page 80 - GALENIKA MEDICAL JOURNAL

Literatura 21. Föger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K,
Pietschmann P. Osteoporosis: Pathophysiology and therapeutic
options. EXCLI J. 2020 Jul 20;19:1017-37.
1. Takahashi TA, Johnson KM. Menopause. Med Clin North Am. 2015 22. Lin YH, Shih YT, Teng MMH. The Impact of the "Osteo" Component of
May;99(3):521-34. Osteosarcopenia on Fragility Fractures in Post-Menopausal Women. Int
2. Gatenby C, Simpson P. Menopause: Physiology, definitions, and J Mol Sci. 2021 May 17;22(10):5256.
symptoms. Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101855. 23. Zanker J, Duque G. Osteosarcopenia: the Path Beyond Controversy. Curr
3. Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Osteoporos Rep. 2020 Apr;18(2):81-4.
Transition: Signs, Symptoms, and Management Options. J Clin 24. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A
Endocrinol Metab. 2021 Jan 1;106(1):1-15. comprehensive overview on osteoporosis and its risk factors. Ther Clin
4. Peacock K, Carlson K, Ketvertis KM, Doerr C. Menopause (Nursing). Risk Manag. 2018 Nov 6;14:2029-49.
2023 Dec 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls 25. Arceo-Mendoza RM, Camacho PM. Postmenopausal Osteoporosis:
Publishing; 2024 Jan–. Latest Guidelines. Endocrinol Metab Clin North Am. 2021 Jun;50(2):167-
5. Vincent AJ, Laven JS. Early Menopause/Premature Ovarian Insufficiency. 78.
Semin Reprod Med. 2020 Sep;38(4-05):235-6. 26. Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-
6. Talaulikar V. Menopause transition: Physiology and symptoms. Best Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E. Current Status of the
Pract Res Clin Obstet Gynaecol. 2022 May;81:3-7. Diagnosis and Management of Osteoporosis. Int J Mol Sci. 2022 Aug
21;23(16):9465.
7. Rosner J, Samardzic T, Sarao MS. Physiology, Female Reproduction.
2022 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls 27. Palacios S. Medical treatment of osteoporosis. Climacteric. 2022
Publishing; 2024 Jan–. Feb;25(1):43-9.
8. Rosato E, Sciarra F, Anastasiadou E, Lenzi A, Venneri MA. Revisiting 28. Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for
the physiological role of androgens in women. Expert Rev Endocrinol the management of osteoporosis. Best Pract Res Clin Endocrinol Metab.
Metab. 2022 Nov;17(6):547-61. 2021 Dec;35(6):101551.
9. Oh H, Wild RA, Manson JE, Bea JW, Shadyab AH, Pfeiffer RM, et 29. Rozenberg S, Vandromme J, Revercez P, Valcarenghi M, Joris A.
al. Obesity, Height, and Serum Androgen Metabolism among Menopause Hormone Therapy in the Management of Postmenopausal
Postmenopausal Women in the Women's Health Initiative Osteoporosis. Cancer J. 2022 May-Jun 01;28(3):204-7.
Observational Study. Cancer Epidemiol Biomarkers Prev. 2021 30. Brown JP. Long-Term Treatment of Postmenopausal Osteoporosis.
Nov;30(11):2018-29. Endocrinol Metab (Seoul). 2021 Jun;36(3):544-52.
10. Crandall CJ, Mehta JM, Manson JE. Management of Menopausal 31. LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ,
Symptoms: A Review. JAMA. 2023 Feb 7;329(5):405-20. et al. The clinician's guide to prevention and treatment of osteoporosis.
11. Sourouni M, Zangger M, Honermann L, Foth D, Stute P. Assessment of Osteoporos Int. 2022 Oct;33(10):2049-102.
the climacteric syndrome: a narrative review. Arch Gynecol Obstet. 2021 32. McPhee C, Aninye IO, Horan L. Recommendations for Improving
Oct;304(4):855-62. Women's Bone Health Throughout the Lifespan. J Womens Health
12. Mitchell CM, Waetjen LE. Genitourinary Changes with Aging. Obstet (Larchmt). 2022 Dec;31(12):1671-6.
Gynecol Clin North Am. 2018 Dec;45(4):737-50. 33. Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, et al.
13. Nair AR, Pillai AJ, Nair N. Cardiovascular Changes in Menopause. Curr Osteoporosis: A Review of Treatment Options. P T. 2018 Feb;43(2):92-
Cardiol Rev. 2021;17(4):e230421187681. 104.
14. Davis SR, Pinkerton J, Santoro N, Simoncini T. Menopause-Biology, 34. Management of osteoporosis in postmenopausal women: the 2021
consequences, supportive care, and therapeutic options. Cell. 2023 Sep position statement of The North American Menopause Society.
14;186(19):4038-58. Menopause. 2021 Sep 1;28(9):973-97.
15. Mehta J, Kling JM, Manson JE. Risks, Benefits, and Treatment Modalities 35. Zhu J, March L. Treating osteoporosis: risks and management. Aust
of Menopausal Hormone Therapy: Current Concepts. Front Endocrinol Prescr. 2022 Oct;45(5):150-7.
(Lausanne). 2021 Mar 26;12:564781.
16. Xiao PL, Cui AY, Hsu CJ, Peng R, Jiang N, Xu XH, et al. Global, regional
prevalence, and risk factors of osteoporosis according to the World Konflikt interesa: Nema
Health Organization diagnostic criteria: a systematic review and meta-
analysis. Osteoporos Int. 2022 Oct;33(10):2137-53.
Primljeno: 14. 02. 2024.
17. Gopinath V. Osteoporosis. Med Clin North Am. 2023 Mar;107(2):213-25. Prihvaćeno: 20. 02. 2024.
18. Anam AK, Insogna K. Update on Osteoporosis Screening and Onlajn: 31. 03. 2024.
Management. Med Clin North Am. 2021 Nov;105(6):1117-34.
19. Yong EL, Logan S. Menopausal osteoporosis: screening, prevention and
treatment. Singapore Med J. 2021 Apr;62(4):159-66.
20. Kanis JA, Cooper C, Rizzoli R, Reginster JY. Scientific Advisory Board of
the European Society for Clinical and Economic Aspects of Osteoporosis
(ESCEO) and the Committees of Scientific Advisors and National
Societies of the International Osteoporosis Foundation (IOF). European
guidance for the diagnosis and management of osteoporosis in
postmenopausal women. Osteoporos Int. 2019 Jan;30(1):3-44.

78 DOI: 10.5937/Galmed2409072B